ArticleMolecular oncology2026
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107.
Jutta Schmitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it